Literature DB >> 8961398

Rapid prescribing change, how do patients respond?

J S Dowell1, D Snadden, J A Dunbar.   

Abstract

The cost of prescribed medication is an increasing burden on health care systems. British general practitioners have been encouraged to reduce their prescribing costs through financial incentives within the fundholding scheme. This study reports on one general practice which reduced prescribing expenditure as part of the move to fundholding. Interviews performed with practice staff and patients were analysed and combined with prescribing statistics and questionnaire data to give a picture of the balance between the experience of patients and practitioners. Fifty-three interviews with 17 patients revealed that most were willing to try cheaper treatments and that dissatisfaction was primarily with the communication they received rather than the change itself. Each patient had to decide how to respond to the change in their medication. The decision-making process and the main factors involved are described and discussed. The experience of having long-standing treatment changed can have an impact on the doctor-patient relationship. This was not found to be a large problem and, it is suggested, can be guarded against. Large-scale economies in prescribing are feasible for some practices, and patients will tolerate such changes if attention is paid to sensitive communication.

Entities:  

Mesh:

Year:  1996        PMID: 8961398     DOI: 10.1016/s0277-9536(96)00050-0

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  3 in total

1.  Challenges in changing to non-chlorofluorocarbon inhalers in the treatment of asthma.

Authors:  T Walley; P Bundred; A Rannard; J Bogg
Journal:  Postgrad Med J       Date:  1999-12       Impact factor: 2.401

2.  Is it possible to reduce polypharmacy in the elderly? A randomised, controlled trial.

Authors:  K H Pitkala; T E Strandberg; R S Tilvis
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  Lessons from the failure of implementing the 'Better Care Better Value' prescribing indicator for renin-angiotensin system drugs in England: a qualitative study of general practitioners' perceptions using behavioural change framework.

Authors:  Amanj Kurdi; Rachel Ann Elliott; Li-Chia Chen
Journal:  BMJ Open       Date:  2020-06-23       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.